Chronic Care Management: Focus on Diabetes

Friday, February 7, 2020 - 8:45-10:45 am
UAN: 0107-9999-20-026-L01-P
0.2 CEU/2.0 hr
This course will provide a clinically-intensive review in the area of diabetes management. Hear the latest on how these agents compare in terms of cardiovascular risks and benefits as well as what to recommend for patients with chronic kidney disease. Discover tips on how to improve adherence to therapy for patients in your practice.
Learning Objectives
Upon successful completion of this application-based CPE activity, participants should be able to:
1. Evaluate the cardiovascular evidence available for commonly used diabetes medications.
2. Apply data from recent cardiovascular outcome trials to individualize and optimize a medication plan for patients with diabetes.
3. Discuss the role of diabetes in the promotion of kidney disease.
4. Review the evidence to support the use of SGLT-2 inhibitors and GLP-1 receptor agonists in decreasing progression of kidney disease in patients with type 2 diabetes.
5. Identify the possible benefits and limitations of technology aids that may aid adherence in patients with diabetes.

Emily Beckett
Emily Beckett, PharmD, BCPS

Clinical Ambulatory Pharmacist
Broadlawns Family Medicine Residency Program
Des Moines, IA

Emily Knezevich

Emily Knezevich, PharmD, BCPS, CDE, FCCP

Associate Professor/Clinical Pharmacist
Creighton University School of Pharmacy & Health Professions
Omaha, NE

Jamie Pitlick

Jamie Pitlick, PharmD, BCPS, BC-ADM

Associate Professor of Pharmacy Practice
Drake University College of Pharmacy and Health Sciences 
Des Moines, IA